187 related articles for article (PubMed ID: 19088534)
1. Nonpolypoid intestinal mantle cell lymphoma resembling MALT lymphoma with successful response to rituximab.
D'Antonio A; Boscaino A; Addesso M; Liguori G; Nappi O
South Med J; 2008 Nov; 101(11):1168-9. PubMed ID: 19088534
[TBL] [Abstract][Full Text] [Related]
2. Non-multiple lymphomatous polyposis form of mantle cell lymphoma in the gastrointestinal tract.
Tamura S; Ohkawauchi K; Yokoyama Y; Higashidani Y; Daibata M; Hiroi M; Yamamori S; Onishi S
J Gastroenterol; 2004 Oct; 39(10):995-1000. PubMed ID: 15549454
[TBL] [Abstract][Full Text] [Related]
3. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
Lenz G; Dreyling M; Hoster E; Wörmann B; Dührsen U; Metzner B; Eimermacher H; Neubauer A; Wandt H; Steinhauer H; Martin S; Heidemann E; Aldaoud A; Parwaresch R; Hasford J; Unterhalt M; Hiddemann W
J Clin Oncol; 2005 Mar; 23(9):1984-92. PubMed ID: 15668467
[TBL] [Abstract][Full Text] [Related]
4. Phase 3 study of frontline rituximab, cyclophosphamide, doxorubicin, and prednisone plus vincristine (R-CHOP) or bortezomib (VR-CAP) in transplantation-unsuitable mantle cell lymphoma (MCL) patients.
Clin Adv Hematol Oncol; 2014 Aug; 12(8 Suppl 16):9-11. PubMed ID: 25768994
[No Abstract] [Full Text] [Related]
5. [Antibody therapy in hematology and oncology - part 1].
Kneba M; Schrader C; Köhne H
Med Klin (Munich); 2008 Dec; 103(12):843-59. PubMed ID: 19099214
[No Abstract] [Full Text] [Related]
6. Extranodal marginal zone B-cell lymphoma most probably of MALT type appearing in CNS as parasagittal extracerebral tumor.
Marinković M; Slavik E; Janković S; Cemerikic V; Radulović D
J Neurosurg Sci; 2006 Mar; 50(1):9-12. PubMed ID: 16557194
[TBL] [Abstract][Full Text] [Related]
7. Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by
Smith MR; Hong F; Li H; Gordon LI; Gascoyne RD; Paietta EM; Advani RH; Forero-Torres A; Horning SJ; Kahl BS
Leukemia; 2017 Feb; 31(2):517-519. PubMed ID: 27780968
[No Abstract] [Full Text] [Related]
8. Lymphomatous polyposis as primary manifestation of mantle cell lymphoma.
Yu SC; Liu KL; Chang LC
Eur J Haematol; 2012 Aug; 89(2):185-6. PubMed ID: 22563740
[No Abstract] [Full Text] [Related]
9. Primary gastric mantle cell lymphoma in a patient with long standing history of Crohn's disease.
Raderer M; Püspök A; Birkner T; Streubel B; Chott A
Leuk Lymphoma; 2004 Jul; 45(7):1459-62. PubMed ID: 15359648
[TBL] [Abstract][Full Text] [Related]
10. Treatment of older patients with mantle-cell lymphoma.
Kluin-Nelemans HC; Hoster E; Hermine O; Walewski J; Trneny M; Geisler CH; Stilgenbauer S; Thieblemont C; Vehling-Kaiser U; Doorduijn JK; Coiffier B; Forstpointner R; Tilly H; Kanz L; Feugier P; Szymczyk M; Hallek M; Kremers S; Lepeu G; Sanhes L; Zijlstra JM; Bouabdallah R; Lugtenburg PJ; Macro M; Pfreundschuh M; Procházka V; Di Raimondo F; Ribrag V; Uppenkamp M; André M; Klapper W; Hiddemann W; Unterhalt M; Dreyling MH
N Engl J Med; 2012 Aug; 367(6):520-31. PubMed ID: 22873532
[TBL] [Abstract][Full Text] [Related]
11. Phase 1 trial of bortezomib plus R-CHOP in previously untreated patients with aggressive non-Hodgkin lymphoma.
Furman RR; Martin P; Ruan J; Cheung YK; Vose JM; LaCasce AS; Elstrom R; Coleman M; Leonard JP
Cancer; 2010 Dec; 116(23):5432-9. PubMed ID: 20665890
[TBL] [Abstract][Full Text] [Related]
12. Treatment of HBV-carrying lymphoma patients with Rituximab and CHOP: a diagnostic and therapeutic challenge.
Skrabs C; Müller C; Agis H; Mannhalter C; Jäger U
Leukemia; 2002 Sep; 16(9):1884-6. PubMed ID: 12200717
[No Abstract] [Full Text] [Related]
13. Mantle-cell lymphoma in the elderly: is it time to CHOP and change?
Farrell K; Rule S
Leuk Lymphoma; 2012 Oct; 53(10):1855-6. PubMed ID: 22616710
[No Abstract] [Full Text] [Related]
14. Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
Nickenig C; Dreyling M; Hoster E; Pfreundschuh M; Trumper L; Reiser M; Wandt H; Lengfelder E; Unterhalt M; Hiddemann W;
Cancer; 2006 Sep; 107(5):1014-22. PubMed ID: 16878325
[TBL] [Abstract][Full Text] [Related]
15. Transplantation for mantle cell lymphoma: is it the right thing to do?
Williams ME
Hematology Am Soc Hematol Educ Program; 2013; 2013():568-74. PubMed ID: 24319233
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of diffuse large B-cell lymphoma].
Gleissner B; Zwick C; Pfreundschuh M
Dtsch Med Wochenschr; 2008 Sep; 133(36):1785-94; quiz 1795-6. PubMed ID: 18767006
[TBL] [Abstract][Full Text] [Related]
17. R-CHOP for mantle cell lymphoma.
Klumpp TR
J Clin Oncol; 2005 Sep; 23(27):6802; author reply 6802-3. PubMed ID: 16170194
[No Abstract] [Full Text] [Related]
18. [Monoclonal gammopathy and primary colonic mantle cell lymphoma].
Mohamed G; Kochlef A; Gargouri D; Kilani A; Elloumi H; Ouakaa A; Belhadj N; Romani M; Kharrat J; Ghorbel A
Rev Med Interne; 2009 Mar; 30(3):279-81. PubMed ID: 18814941
[TBL] [Abstract][Full Text] [Related]
19. Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.
Voulgarelis M; Giannouli S; Anagnostou D; Tzioufas AG
Rheumatology (Oxford); 2004 Aug; 43(8):1050-3. PubMed ID: 15187246
[TBL] [Abstract][Full Text] [Related]
20. [Duodenal polyposis disclosing mantle-cell lymphoma].
Moulin O; Boucher E; Samson T; Coutant G; Helie C; Algayres JP
Gastroenterol Clin Biol; 2002 Nov; 26(11):1055. PubMed ID: 12483144
[No Abstract] [Full Text] [Related]
[Next] [New Search]
